Literature DB >> 33024326

Drug-resistant epilepsy - time to target mechanisms.

Holger Lerche1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 33024326     DOI： 10.1038/s41582-020-00419-y

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  5 in total

1.  Single-cell transcriptomics and surface epitope detection in human brain epileptic lesions identifies pro-inflammatory signaling.

Authors:  Pavanish Kumar; Amanda Lim; Sharifah Nur Hazirah; Camillus Jian Hui Chua; Adeline Ngoh; Su Li Poh; Tong Hong Yeo; Jocelyn Lim; Simon Ling; Nursyuhadah Binte Sutamam; Enrico Petretto; David Chyi Yeu Low; Li Zeng; Eng-King Tan; Thaschawee Arkachaisri; Joo Guan Yeo; Florent Ginhoux; Derrick Chan; Salvatore Albani
Journal:  Nat Neurosci       Date:  2022-06-23       Impact factor: 28.771

2.  Current Principles in the Management of Drug-Resistant Epilepsy.

Authors:  Nathan A Shlobin; Josemir W Sander
Journal:  CNS Drugs       Date:  2022-05-20       Impact factor: 6.497

3.  Limited Ability to Adjust N2 Amplitude During Dual Task Walking in People With Drug-Resistant Juvenile Myoclonic Epilepsy.

Authors:  Mor Yam; Sigal Glatt; Shai Nosatzki; Anat Mirelman; Jeffrey M Hausdorff; Lilach Goldstein; Nir Giladi; Firas Fahoum; Inbal Maidan
Journal:  Front Neurol       Date:  2022-02-07       Impact factor: 4.003

Review 4.  Antiseizure medication discovery: Recent and future paradigm shifts.

Authors:  Alan Talevi
Journal:  Epilepsia Open       Date:  2022-02-07

5.  Neurology at the crossroads.

Authors: 
Journal:  Nat Rev Neurol       Date:  2020-11       Impact factor: 42.937
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.